Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease

被引：62

作者：

Stacy, M.

Hauser, R.

机构：

[1] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27705 USA

[2] Univ S Florida, Coll Med, Tampa, FL USA

来源：

JOURNAL OF NEURAL TRANSMISSION | 2007年 / 114卷 / 02期

关键词：

Parkinson's disease; wearing-off; non-motor fluctuations;

D O I：

10.1007/s00702-006-0554-y

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We previously reported that the use of a specifically designed Wearing-Off Questionnaire (WOQ) identified symptoms of wearing-off more frequently than standard assessments conducted by movement disorder specialists during a routine office visit. In the previous study we used a WOQ of 32 symptoms; however this tool was not designed for daily use. In this paper we describe the retrospective development of a simpler, 19-symptom WOQ more suitable for routine clinical use.

引用

页码：211 / 217

页数：7

共 14 条

[1] Levodopa: why the controversy? [J].

Agid, Y ;

Olanow, CW ;

Mizuno, Y .

LANCET, 2002, 360 (9332) :575-575

[2] Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].

Ahlskog, JE ;

Muenter, MD .

MOVEMENT DISORDERS, 2001, 16 (03) :448-458

[3] The non-motor symptom complex of Parkinson's disease: A comprehensive assessment is essential [J].

Chaudhuri K.R. ;

Yates L. ;

Martinez-Martin P. .

Current Neurology and Neuroscience Reports, 2005, 5 (4) :275-283

[4] Health-related quality of life and healthcare utilisation in patients with Parkinson's disease - Impact of motor fluctuations and dyskinesias [J].

Dodel, RC ;

Berger, K ;

Oertel, WH .

PHARMACOECONOMICS, 2001, 19 (10) :1013-1038

[5] Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 [J].

Goetz, CG ;

Poewe, W ;

Rascol, O ;

Sampaio, C .

MOVEMENT DISORDERS, 2005, 20 (05) :523-539

[6] The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations [J].

Goetz, CG ;

Poewe, W ;

Rascol, O ;

Sampaio, C ;

Stebbins, GT ;

Fahn, S ;

Lang, AE ;

Martinez-Martin, P ;

Tilley, B ;

Van Hilten, B ;

Kleczka, C ;

Seidl, L .

MOVEMENT DISORDERS, 2003, 18 (07) :738-750

[7] Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial [J].

Holloway, R ;

Shoulson, I ;

Kieburtz, K ;

McDermott, M ;

Tariot, P ;

Kamp, C ;

Day, D ;

Shinaman, A ;

Fahn, S ;

Lang, A ;

Marek, K ;

Seibyl, J ;

Weiner, W ;

Welsh, M ;

Pahwa, R ;

Coe, S ;

Barclay, L ;

Sutherland, L ;

Hildebrand, K ;

Hubble, J ;

Weeks, C ;

LeWitt, P ;

Miyasaki, J ;

Duff, J ;

Sime, E ;

Suchowersky, O ;

Stacy, M ;

Kurth, M ;

Brewer, M ;

Harrigan, M ;

Russell, DS ;

Fussell, B ;

Ford, B ;

Dillon, S ;

Hammerstad, J ;

Stone, C ;

Riley, D ;

Rainey, P ;

Standaert, D ;

Tennis, M ;

Wooten, F ;

Rost-Ruffner, E ;

Factor, S ;

Brown, D ;

Jankovic, J ;

Atassi, F ;

Kurlan, R ;

Gardiner, I ;

Panisset, M ;

Amyot, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15) :1931-1938

[8]

MARSDEN CD, 1977, LANCET, V1, P345

[9] COMT inhibitors in Parkinson's disease - Can they prevent and/or reverse levodopa-induced motor complications? [J].

Olanow, CW ;

Stocchi, F .

NEUROLOGY, 2004, 62 (01) :S72-S81

[10]

Shoulson I, 1996, ANN NEUROL, V39, P29

← 1 2 →